RU2000128037A - LIST OF ANTI-TUMOR ANALYSIS COMPOSITION - Google Patents
LIST OF ANTI-TUMOR ANALYSIS COMPOSITIONInfo
- Publication number
- RU2000128037A RU2000128037A RU2000128037/14A RU2000128037A RU2000128037A RU 2000128037 A RU2000128037 A RU 2000128037A RU 2000128037/14 A RU2000128037/14 A RU 2000128037/14A RU 2000128037 A RU2000128037 A RU 2000128037A RU 2000128037 A RU2000128037 A RU 2000128037A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- composition
- composition according
- alkane
- cancer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 16
- 230000000259 anti-tumor Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 7
- -1 alkene compound Chemical class 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- WWUZIQQURGPMPG-KRWOKUGFSA-N Sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 210000000481 Breast Anatomy 0.000 claims 1
- 210000001072 Colon Anatomy 0.000 claims 1
- 210000003989 Endothelium, Vascular Anatomy 0.000 claims 1
- 210000003238 Esophagus Anatomy 0.000 claims 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 claims 1
- 210000003128 Head Anatomy 0.000 claims 1
- 206010024324 Leukaemias Diseases 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010025650 Malignant melanoma Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 210000003739 Neck Anatomy 0.000 claims 1
- 206010025310 Other lymphomas Diseases 0.000 claims 1
- 210000001672 Ovary Anatomy 0.000 claims 1
- 210000000496 Pancreas Anatomy 0.000 claims 1
- 210000002307 Prostate Anatomy 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 241000237543 Spisula Species 0.000 claims 1
- 210000001550 Testis Anatomy 0.000 claims 1
- 210000001685 Thyroid Gland Anatomy 0.000 claims 1
- 210000003932 Urinary Bladder Anatomy 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 230000000975 bioactive Effects 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002062 proliferating Effects 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
- 230000000989 vascularization Effects 0.000 claims 1
Claims (18)
списулозина 285 (1), n = 12; списулозина 299 (2), n = 14; 13; списулозина 313 (3), n = 14;
сфингозина (4), n = 12, и нонадека-4-сфингенина (5), n = 13; и
сфинга-4,10-диена (6).6. The composition of claim 1, wherein the compound is selected from:
spisulosin 285 (1), n = 12; spisulosin 299 (2), n = 14; thirteen; spisulosin 313 (3), n = 14;
sphingosine (4), n = 12, and non-inadequate-4-sphingenin (5), n = 13; and
sphinga-4,10-diene (6).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/058,456 US6107520A (en) | 1997-04-15 | 1998-04-10 | Spisulosine compounds |
US09/058,456 | 1998-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000128037A true RU2000128037A (en) | 2003-03-27 |
RU2225710C2 RU2225710C2 (en) | 2004-03-20 |
Family
ID=22016916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000128037/15A RU2225710C2 (en) | 1998-04-10 | 1999-04-09 | Spisulosine compounds eliciting antitumor activity |
Country Status (24)
Country | Link |
---|---|
US (1) | US6107520A (en) |
EP (1) | EP1069894B1 (en) |
JP (1) | JP2002511410A (en) |
KR (1) | KR100568964B1 (en) |
CN (1) | CN1335770A (en) |
AT (1) | ATE303139T1 (en) |
AU (1) | AU763981B2 (en) |
BG (1) | BG64970B1 (en) |
BR (1) | BR9910120A (en) |
CA (1) | CA2328126A1 (en) |
DE (1) | DE69927007T2 (en) |
DK (1) | DK1069894T3 (en) |
ES (1) | ES2248995T3 (en) |
HK (1) | HK1042048A1 (en) |
HU (1) | HUP0105443A3 (en) |
IL (1) | IL138886A0 (en) |
MX (1) | MXPA00009930A (en) |
NO (1) | NO20005052L (en) |
PL (1) | PL343381A1 (en) |
RU (1) | RU2225710C2 (en) |
SK (1) | SK15082000A3 (en) |
TR (1) | TR200002955T2 (en) |
UA (1) | UA72208C2 (en) |
WO (1) | WO1999052521A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306911B1 (en) * | 2000-02-07 | 2001-10-23 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted amino acids as neutral sphingomyelinase inhibitors |
AU2001233873B2 (en) * | 2000-02-16 | 2006-03-02 | Pharma Mar, S.A. | Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
DE60131076T2 (en) * | 2000-06-06 | 2008-07-31 | Pharma Mar, S.A., Tres Cantos | ANTITUMORAL COMPOUNDS |
FR2811556B1 (en) * | 2000-07-11 | 2002-09-06 | Oreal | COMPOSITION COMPRISING A CERAMIDE PRECURSOR, USE FOR IMPROVING THE NATURAL OR RECONSTRUCTED SKIN, EQUIVALENT OF THE SKIN OBTAINED |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
EP1587530A2 (en) * | 2003-01-20 | 2005-10-26 | VIB vzw | The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors |
CN100360515C (en) * | 2004-04-09 | 2008-01-09 | 中国科学院上海药物研究所 | Lingshui alcohol with anti-cancer activity, its preparation and use |
WO2006034849A1 (en) * | 2004-09-27 | 2006-04-06 | Pharma Mar, S.A., Sociedad Unipersonal | Antitumoral pharmaceutical compositions comprising a spisulosine and a cyclodextrin |
CA2691251A1 (en) * | 2007-06-19 | 2008-12-24 | Yoshikazu Ohta | Preventive/remedy for cancer |
CN102206163B (en) * | 2011-05-06 | 2013-07-10 | 中国海洋大学 | Separation and preparation method for long-chain base |
WO2014118556A2 (en) * | 2013-01-31 | 2014-08-07 | Research Foundation Of The City University Of New York | Selective inhibitors and allosteric activators of sphingosine kinase |
CN104758275A (en) * | 2015-03-05 | 2015-07-08 | 青岛申达高新技术开发有限公司 | Pharmaceutical composition for treatment of colon cancer and application thereof |
JOP20190254A1 (en) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | Antitumoral compounds |
CN112063606A (en) * | 2020-08-25 | 2020-12-11 | 山东省科学院生物研究所 | Method for rapidly extracting shellfish digestive endogenous enzyme |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816450A (en) * | 1986-09-15 | 1989-03-28 | Duke University | Inhibition of protein kinase C by long-chain bases |
US5190876A (en) * | 1988-12-27 | 1993-03-02 | Emory University | Method of modifying cellular differentiation and function and compositions therefor |
CA2007507C (en) * | 1989-02-03 | 1998-05-19 | Yasuyuki Igarashi | Sphingosine and n-methyl-sphingosine as inhibitor of cell growth |
US5583160A (en) * | 1989-02-03 | 1996-12-10 | The Biomembrane Institute | Methylsphingosine used to treat apoptosis |
US5426228A (en) * | 1994-06-27 | 1995-06-20 | Koskinen; Ari | General method for preparation of sphingosine bases and their analogues |
EP0821068A3 (en) * | 1996-03-29 | 1999-06-02 | Rohm And Haas Company | Novel sphingolipids and a process thereto |
-
1998
- 1998-04-10 US US09/058,456 patent/US6107520A/en not_active Ceased
-
1999
- 1999-04-09 WO PCT/GB1999/001091 patent/WO1999052521A1/en active IP Right Grant
- 1999-04-09 SK SK1508-2000A patent/SK15082000A3/en unknown
- 1999-04-09 RU RU2000128037/15A patent/RU2225710C2/en not_active IP Right Cessation
- 1999-04-09 IL IL13888699A patent/IL138886A0/en unknown
- 1999-04-09 DK DK99915898T patent/DK1069894T3/en active
- 1999-04-09 AU AU34321/99A patent/AU763981B2/en not_active Ceased
- 1999-04-09 JP JP2000543131A patent/JP2002511410A/en not_active Abandoned
- 1999-04-09 MX MXPA00009930A patent/MXPA00009930A/en active IP Right Grant
- 1999-04-09 DE DE69927007T patent/DE69927007T2/en not_active Expired - Fee Related
- 1999-04-09 TR TR2000/02955T patent/TR200002955T2/en unknown
- 1999-04-09 CA CA002328126A patent/CA2328126A1/en not_active Abandoned
- 1999-04-09 EP EP99915898A patent/EP1069894B1/en not_active Expired - Lifetime
- 1999-04-09 HU HU0105443A patent/HUP0105443A3/en unknown
- 1999-04-09 ES ES99915898T patent/ES2248995T3/en not_active Expired - Lifetime
- 1999-04-09 AT AT99915898T patent/ATE303139T1/en not_active IP Right Cessation
- 1999-04-09 BR BR9910120-3A patent/BR9910120A/en not_active Application Discontinuation
- 1999-04-09 PL PL99343381A patent/PL343381A1/en not_active IP Right Cessation
- 1999-04-09 CN CN99807084A patent/CN1335770A/en active Pending
- 1999-04-09 KR KR1020007011292A patent/KR100568964B1/en not_active IP Right Cessation
- 1999-09-04 UA UA2000105675A patent/UA72208C2/en unknown
-
2000
- 2000-10-06 NO NO20005052A patent/NO20005052L/en not_active Application Discontinuation
- 2000-11-09 BG BG104935A patent/BG64970B1/en unknown
-
2002
- 2002-05-23 HK HK02103875.2A patent/HK1042048A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000128037A (en) | LIST OF ANTI-TUMOR ANALYSIS COMPOSITION | |
AU2015205588B2 (en) | Duocarmycin ADCs for use in treatment of endometrial cancer | |
RU2006122853A (en) | DIARYM UREA DERIVATIVES FOR TREATMENT OF DISEASES DEPENDING ON PROTEINKINASE | |
HK1106736A1 (en) | Combination therapy comprising anti-cd20 and anti-cd40 antibodies for the treatment of b cell-related cancers | |
RU2225710C2 (en) | Spisulosine compounds eliciting antitumor activity | |
BR112021001750A2 (en) | pharmaceutical composition | |
JP2003504413A (en) | Combination preparation containing an antitumor substance | |
CA2095141A1 (en) | Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents | |
JP2004503564A5 (en) | ||
NZ511280A (en) | Treatment of tumors by administration of growth hormone releasing compounds and their antagonists | |
Schlag | Adjuvant chemotherapy in gastric cancer | |
JP2002534378A (en) | Synergistic tumoricidal response induced by histamine | |
RU93042874A (en) | POLYPEPTIDE NATURE COMPOUNDS, METHOD FOR THEIR PRODUCTION, A COMPOSITION ON THEIR BASIS, THEIR APPLICATION IN ANTI-CANCER THERAPY | |
EA006295B1 (en) | Use of distamycin derivatives for antitumor therapy | |
EA200201068A1 (en) | METHOD AND COMPOSITION FOR CANCER TREATMENT BY INTRODUCTION OF CHEMOTHERAPEUTIC MEANS CAUSING APOPTOSIS | |
CA2501089A1 (en) | 4-methylhexanoic kahalaide f compound | |
JP2018527402A (en) | SYD985 treatment of patients with T-DM1 refractory cancer | |
AU2003241024A1 (en) | Methods and compositions for radioimmunotherapy of brain and cns tumors | |
JP2006517195A5 (en) | ||
RU2005115102A (en) | NEW TUMOR COMPOUNDS | |
JP7317343B2 (en) | Preventive or therapeutic agent for breast cancer and agent for suppressing proliferation of breast cancer cells | |
Andratschke et al. | Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody | |
WO2005072292A2 (en) | Methods for enhancing radiation therapy | |
US20190015393A1 (en) | The use of a temporary inhibitor of p53 for preventing or reducing cancer relapse | |
JP2003513881A5 (en) |